Alagene is on an ambitious mission to become the leading bio-foundry of Israel and the Middle East. The company is focused on creating the Israeli infrastructure for synthetic biology innovation, focused on a wide variety of applications and spanning the project lifecycle, from ideation to proof-of-concept. The company is based in Herzliya and Rehovot. This unique company is a joint venture between hyLabs (Israel’s foremost bio-services provider), Reichman University (home of Israel’s first synthetic biology research institute), Michael Eisenberg (Israel’s leading venture capitalist), and the Israeli Innovation Authority.
Employee counts updated on a monthly basis.